- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01090869
Physical Training Per se (TPS)
March 22, 2010 updated by: University of Copenhagen
Physical Activity is Healthy - Effect of Weight Loss or Physical Training Per se?
The investigators aimed to evaluate the health benefits of physical training per se, weight loss per se and exercise-induced weight loss in young, overweight men.
The investigators hypothesized that physical training would have independent effects on various health parameters (insulin sensitivity, fasting glucose and insulin, total and abdominal fat mass, waist circumference, blood pressure and key muscle proteins), and that a concomitant weight loss from physical activity would increase the effect.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
At baseline, during the intervention and in the week following the intervention participants underwent a panel of tests:
- Cardio respiratory fitness
- blood pressure
- anthropometric measures
At baseline and after the intervention a hyperinsulinemic, euglycemic clamp were performed to asses insulin sensitivity.
Tissue and blood samples were also collected for further analysis:
- Total-protein analysis of selected proteins
- Fasting plasma glucose, insulin and free fatty acids
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2200
- University of Copenhagen, Faculty Of Health Sciences, Department of Biomedical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Overweight (body mass index 25-30 kg/m2)
- Weight stable (±2 kg during the past 6 months)
- Body fat% >25%,
- Maximal oxygen uptake <45 mL/min/kg
- Sedentary and healthy according to interview
- Fasting glucose <6.1 mmol/L
- Blood pressure <140/90 mmHg
- No first degree relatives with type-2-diabetes
Exclusion Criteria:
- Resistance training
- Inability to meet intervention criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Physical training, unchanged diet
Daily endurance training equivalent to 600 kcal/day and unchanged habitual diet
|
Participants were randomly assigned to a 12-week intervention in one of four groups: Training (T), energy-reduced Diet (D), Training and increased- Diet (T-iD) or Control (C).
The interventions consisted of: T: increased physical activity through daily endurance training equivalent to 600 kcal/day, unchanged diet; D: sedentary lifestyle, reduced diet by 600 kcal/day primarily through reducing serving sizes and substituting energy dense with less energy dense nutrients; T-iD: increased physical activity through daily endurance training equivalent to 600 kcal/day, increased diet by 600 kcal/day primarily through increasing serving sizes and consuming energy dense nutrients; C: sedentary lifestyle and unchanged diet.
|
Active Comparator: Physical training, increased diet
Daily endurance training equivalent to 600 kcal/day, and increased diet by 600 kcal/day.
|
Participants were randomly assigned to a 12-week intervention in one of four groups: Training (T), energy-reduced Diet (D), Training and increased- Diet (T-iD) or Control (C).
The interventions consisted of: T: increased physical activity through daily endurance training equivalent to 600 kcal/day, unchanged diet; D: sedentary lifestyle, reduced diet by 600 kcal/day primarily through reducing serving sizes and substituting energy dense with less energy dense nutrients; T-iD: increased physical activity through daily endurance training equivalent to 600 kcal/day, increased diet by 600 kcal/day primarily through increasing serving sizes and consuming energy dense nutrients; C: sedentary lifestyle and unchanged diet.
|
Active Comparator: Diet, unchanged physical activity
Energy-reduced diet by 600 kcal/day, and unchanged sedentary lifestyle
|
Participants were randomly assigned to a 12-week intervention in one of four groups: Training (T), energy-reduced Diet (D), Training and increased- Diet (T-iD) or Control (C).
The interventions consisted of: T: increased physical activity through daily endurance training equivalent to 600 kcal/day, unchanged diet; D: sedentary lifestyle, reduced diet by 600 kcal/day primarily through reducing serving sizes and substituting energy dense with less energy dense nutrients; T-iD: increased physical activity through daily endurance training equivalent to 600 kcal/day, increased diet by 600 kcal/day primarily through increasing serving sizes and consuming energy dense nutrients; C: sedentary lifestyle and unchanged diet.
|
No Intervention: Control
Unchanged sedentary lifestyle and diet
|
Participants were randomly assigned to a 12-week intervention in one of four groups: Training (T), energy-reduced Diet (D), Training and increased- Diet (T-iD) or Control (C).
The interventions consisted of: T: increased physical activity through daily endurance training equivalent to 600 kcal/day, unchanged diet; D: sedentary lifestyle, reduced diet by 600 kcal/day primarily through reducing serving sizes and substituting energy dense with less energy dense nutrients; T-iD: increased physical activity through daily endurance training equivalent to 600 kcal/day, increased diet by 600 kcal/day primarily through increasing serving sizes and consuming energy dense nutrients; C: sedentary lifestyle and unchanged diet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in insulin sensitivity
Time Frame: week 0 and 13
|
Before and after the 12 week interventions a 1-step, 120 min, hyperinsulinaemic, euglycemic clamp was performed.
After an initial 2mL bolus of insulin infusate, insulin was infused at 40 microU/min/kg.
|
week 0 and 13
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in body composition
Time Frame: DEXA: week 0, 2, 6, 10, and 13; MRI: Week 0 and 13
|
Before, during and after the 12-week interventions changes in: Body mass, Lean body mass, Fat mass, Abdominal fat mass, and Viceral and subcutaneous fat were assesed by DEXA and MRI scans.
|
DEXA: week 0, 2, 6, 10, and 13; MRI: Week 0 and 13
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Pernille Nordby, MSc, University of Copenhagen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2007
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
March 16, 2010
First Submitted That Met QC Criteria
March 22, 2010
First Posted (Estimate)
March 23, 2010
Study Record Updates
Last Update Posted (Estimate)
March 23, 2010
Last Update Submitted That Met QC Criteria
March 22, 2010
Last Verified
October 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-KF-2006-6443
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Sensitivity
-
Paloma Almeda-ValdésCompleted
-
Ingredion IncorporatedUnknownFocus of the Study is Insulin SensitivityUnited States
-
University of Colorado, DenverRecruitingEndothelial Dysfunction | Vascular Stiffness | Insulin Sensitivity/Resistance | TransgenderismUnited States
-
University of Texas, El PasoCompletedInsulin Sensitivity/ResistanceUnited States
-
Rigshospitalet, DenmarkUnknownInsulin Sensitivity and Lipid Metabolism
-
Maastricht University Medical CenterCompletedVascular Function | Nitrate | Brain Insulin-sensitivityNetherlands
-
University of Alabama at BirminghamNot yet recruitingCardiovascular Diseases | Obesity | Insulin Sensitivity/Resistance | Metabolic Disease | Energy Expenditure | MetabolismUnited States
-
University Hospital TuebingenCompletedInsulin SensitivityGermany
-
University of CopenhagenCompleted
-
Marjukka KolehmainenKuopio University HospitalCompleted
Clinical Trials on 12 weeks of lifestyle change
-
Scripps Center for Integrative MedicineUnknown
-
VA Office of Research and DevelopmentBaltimore VA Medical Center; South Texas Veterans Health Care SystemNot yet recruitingObesity | Post-COVID ConditionsUnited States
-
Dokuz Eylul UniversityNot yet recruitingPolycystic Ovary Syndrome
-
California Polytechnic State University-San Luis...The Miriam Hospital; Bradley HospitalRecruitingObesity | Diet, Healthy | Inactivity, PhysicalUnited States
-
University of British ColumbiaUnknown
-
McGill UniversityCanadian Institutes of Health Research (CIHR); McMaster University; Jewish Rehabilitation... and other collaboratorsRecruiting
-
Cairo UniversityRecruitingDry Eye | Diet Habit | Physical InactivityEgypt
-
University of Modena and Reggio EmiliaUnknownExercise Addiction | Maternal Obesity Complicating Pregnancy | High-Risk Pregnancy | Inflammatory Status During Preganancy | Maternal Body CompositionItaly
-
Leigh Ann Callahan, MDCompleted
-
Organon and CoCompleted